{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:53:39Z","timestamp":1792601619377,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Ceftazidime\u2013avibactam (CZA) is one of the effective antibiotics used for the treatment of carbapenem-resistant <jats:italic>Klebsiella pneumoniae<\/jats:italic> (CRKP) infections, but its resistance rate has increased recently. Previous studies have focused on the mechanisms of CZA resistance, while its heteroresistance in CRKP remains poorly understood. This study aimed to investigate the characteristics and mechanisms of CZA heteroresistance in CRKP isolates. A total of 311 CRKP clinical strains were collected in China from 2020 to 2022. The MICs of CZA and other antibiotics against <jats:italic>K. pneumoniae<\/jats:italic> were determined by broth microdilution method. The occurrence of CZA heteroresistance in CRKP was evaluated with population analysis profiling (PAP) and their characteristics were detected by polymerase chain reaction (PCR). The underlying mechanism of CZA heteroresistance in CRKP strains was investigated by molecular sequencing, whole genome sequencing (WGS), quantitative real-time PCR (qRT-PCR), and <jats:italic>in vitro<\/jats:italic> functional experiments. Strategies for preventing the emergence of CZA heteroresistance and alternative treatment options for strains exhibiting CZA heteroresistance were further explored. Thirty-four (12.4%) CZA-susceptible CRKP isolates were found to exhibit heteroresistance to CZA. All heteroresistant strains belonged to KPC-2 (97.1%) or KPC-3 (2.9%). The dominant multilocus sequence typing (MLST) was ST11 (64.7%) and the prevalent capsular serotypes were KL47 (38.2%) and KL64 (32.4%). Imipenem-relebactam and meropenem-vaborbactam still exhibited excellent antimicrobial activity against the resistant subpopulations of CZA heteroresistant strains. No significant mutations were found in KPC, OmpK35\/36, PBP2\/3, and LamB in resistant subpopulations. The relative expression and copy number of <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub> were significantly upregulated in 47.1% and 35.3% of the resistant subpopulations compared with their parental strains, respectively. Silencing <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub> expression significantly decreased the CZA MIC in resistant subpopulations with high <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub> expression and hindered the emergence of CZA heteroresistance in their parental strains. Moreover, increasing the avibactam concentration to 8 or 16 mg\/L or combining CZA with 0.5 \u00d7 MIC tigecycline significantly suppressed the formation of CZA heteroresistance (<jats:italic>P<\/jats:italic>&amp;lt;0.05). In conclusion, we identified the occurrence of CZA heteroresistance in CRKP in China, which was attributed to the overexpression of KPC. Increasing the concentration of avibactam or combining CZA with tigecycline could effectively prevent the development of CZA heteroresistance in CRKP isolates. Besides, imipenem-relebactam and meropenem-vaborbactam may serve as alternative therapeutic options when clinical isolates with CZA heteroresistance are detected.<\/jats:p>","DOI":"10.3389\/fcimb.2024.1450530","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:50:57Z","timestamp":1733467857000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Overexpression of KPC contributes to ceftazidime-avibactam heteroresistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae"],"prefix":"10.3389","volume":"14","author":[{"given":"Yitan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiandi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhuo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingdong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e00759","DOI":"10.1128\/mSystems.00759-20","article-title":"Characterization of the plasmidome encoding carbapenemase and mechanisms for dissemination of carbapenem-resistant enterobacteriaceae","volume":"5","author":"Abe","year":"2020","journal-title":"mSystems"},{"key":"B2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41579-019-0218-1","article-title":"Mechanisms and clinical relevance of bacterial heteroresistance","volume":"17","author":"Andersson","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007726","article-title":"Heteroresistance: A cause of unexplained antibiotic treatment failure","volume":"15","author":"Band","year":"2019","journal-title":"PloS Pathog."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1093\/jac\/dky213","article-title":"Ceftazidime\/avibactam versus standard-of-care agents against carbapenem-resistant Enterobacteriaceae harbouring blaKPC in a one-compartment pharmacokinetic\/pharmacodynamic model","volume":"73","author":"Barber","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"B5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/jac\/dkw435","article-title":"IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2","volume":"72","author":"Beyrouthy","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(21)00194-8","article-title":"Widespread cefiderocol heteroresistance in carbapenem-resistant Gram-negative pathogens","volume":"21","author":"Choby","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B7","volume-title":"Performance standard for antimicrobial susceptibility testing: Thirty-one informational supplement M100-S34","year":"2024"},{"key":"B8","doi-asserted-by":"publisher","first-page":"27960","DOI":"10.1074\/jbc.M113.485979","article-title":"Kinetics of avibactam inhibition against Class A, C, and D \u03b2-lactamases","volume":"288","author":"Ehmann","year":"2013","journal-title":"J. Biol. Chem."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00890-21","article-title":"KPC-mediated resistance to ceftazidime-avibactam and collateral effects in Klebsiella pneumoniae","volume":"65","author":"Findlay","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e02101","DOI":"10.1128\/AAC.02101-17","article-title":"Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in bla(KPC-2)-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates","volume":"62","author":"Giddins","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/a-0748-5548","article-title":"Review of Clinical Pharmacokinetics of Avibactam, A Newly Approved non-\u03b2 lactam \u03b2-lactamase Inhibitor Drug, In Combination Use With Ceftazidime","volume":"69","author":"Giri","year":"2019","journal-title":"Drug Res. (Stuttg)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1080\/22221751.2021.1984182","article-title":"Mutations in porin LamB contribute to ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae","volume":"10","author":"Guo","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/22221751.2020.1799721","article-title":"Prevalence, risk factors and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in patients from Zhejiang, China 2008-2018","volume":"9","author":"Hu","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/s41564-024-01612-1","article-title":"Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-centre study","volume":"9","author":"Hu","year":"2024","journal-title":"Nat. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.2147\/IDR.S371285","article-title":"Diversity of ceftazidime-avibactam resistance mechanism in KPC2-producing klebsiella pneumoniae under antibiotic selection pressure","volume":"15","author":"Jiang","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/Spectrum.01010-21","article-title":"Tigecycline heteroresistance and resistance mechanism in clinical isolates of acinetobacter baumannii","volume":"9","author":"Jo","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12020234","article-title":"Carbapenem-resistant klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options","volume":"12","author":"Karampatakis","year":"2023","journal-title":"Antibiot. (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2023.106090","article-title":"Efficacy and safety of ceftazidime-avibactam compared to other antimicrobials for the treatment of infections caused by carbapenem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis","volume":"179","author":"Karampatakis","year":"2023","journal-title":"Microb. Pathog."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01082-20","article-title":"Decreased incidence of methicillin-resistant staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital","volume":"64","author":"Kim","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00895","article-title":"Global dissemination of carbapenemase-producing klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods","volume":"7","author":"Lee","year":"2016","journal-title":"Front. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1356353","article-title":"Emergence of eravacycline heteroresistance in carbapenem-resistant Acinetobacter baumannii isolates in China","volume":"14","author":"Li","year":"2024","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13756-023-01331-y","article-title":"Infection with Carbapenem-resistant Hypervirulent Klebsiella pneumoniae: clinical, virulence and molecular epidemiological characteristics","volume":"12","author":"Li","year":"2023","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"B23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbrc.2006.01.130","article-title":"rmlB and rmlC genes are essential for growth of mycobacteria","volume":"342","author":"Li","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jiph.2022.04.002","article-title":"Emergence of ceftazidime-avibactam resistance due to a novel blaKPC-2 mutation during treatment of carbapenem-resistant Klebsiella pneumoniae infections","volume":"15","author":"Liao","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"B25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jgar.2020.09.004","article-title":"Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: A review over the last 10 years","volume":"23","author":"Liao","year":"2020","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.02097-19","article-title":"Omadacycline Efficacy against Enterococcus faecalis Isolated in China: In Vitro Activity, Heteroresistance, and Resistance Mechanisms","volume":"64","author":"Lin","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.00436","article-title":"Characteristics of Hypervirulent Klebsiella pneumoniae: Does Low Expression of rmpA Contribute to the Absence of Hypervirulence","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Microbiol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02029","article-title":"Ceftazidime\/avibactam Improves the Antibacterial Efficacy of Polymyxin B Against Polymyxin B Heteroresistant KPC-2-Producing Klebsiella pneumoniae and Hinders Emergence of Resistant Subpopulation in vitro","volume":"10","author":"Ma","year":"2019","journal-title":"Front. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106635","article-title":"Cefiderocol heteroresistance in Klebsiella pneumoniae is linked to mutations in the siderophore receptor cirA and \u03b2-lactamase activities","volume":"60","author":"Moon","year":"2022","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkl697","article-title":"Paired termini stabilize antisense RNAs and enhance conditional gene silencing in Escherichia coli","volume":"34","author":"Nakashima","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e00989","DOI":"10.1128\/AAC.00989-17","article-title":"Resistance to ceftazidime-avibactam is due to transposition of KPC in a porin-deficient strain of klebsiella pneumoniae with increased efflux activity","volume":"61","author":"Nelson","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41564-018-0342-0","article-title":"The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification","volume":"4","author":"Nicoloff","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10121","article-title":"The Bacteria Genome Pipeline (BAGEP): an automated, scalable workflow for bacteria genomes with Snakemake","volume":"8","author":"Olawoye","year":"2020","journal-title":"PeerJ"},{"key":"B34","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1128\/AAC.00693-09","article-title":"Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase","volume":"54","author":"Papp-Wallace","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000349","article-title":"Whole-genome sequencing resolves a polyclonal outbreak by extended-spectrum beta-lactam and carbapenem-resistant Klebsiella pneumoniae in a Portuguese tertiary-care hospital","volume":"7","author":"Perdig\u00e3o","year":"2020","journal-title":"Microb. Genomics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.18502\/ijm.v14i1.8799","article-title":"Analysis of carbapenemases genes of carbapenem-resistant Klebsiella pneumoniae isolated from Tehran heart center","volume":"14","author":"Pourgholi","year":"2022","journal-title":"Iran J. Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1016\/j.scib.2023.09.040","article-title":"Superbugs\u201d with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China","volume":"68","author":"Pu","year":"2023","journal-title":"Sci. Bull. (Beijing)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"S206","DOI":"10.1093\/infdis\/jiz622","article-title":"The colonization of carbapenem-resistant Klebsiella pneumoniae: epidemiology, resistance mechanisms, and risk factors in patients admitted to intensive care units in China","volume":"221","author":"Qin","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/genes14071426","article-title":"Insight into Antibiotic Synergy Combinations for Eliminating Colistin Heteroresistant Klebsiella pneumoniae","volume":"14","author":"Rajakani","year":"2023","journal-title":"Genes (Basel)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"33549","DOI":"10.1073\/pnas.2012254117","article-title":"Exopolysaccharide defects cause hyper-thymineless death in Escherichia coli via massive loss of chromosomal DNA and cell lysis","volume":"117","author":"Rao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/INF.0000000000001859","article-title":"Ceftazidime\u2013avibactam antimicrobial activity and spectrum when tested against gram-negative organisms from pediatric patients: results from the INFORM surveillance program (United states 2011\u20132015)","volume":"37","author":"Sader","year":"2018","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B42","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s00284-022-03087-x","article-title":"Whole-Genome Sequence Analysis of Carbapenem-Heteroresistant Klebsiella pneumoniae and Escherichia coli Isolates","volume":"79","author":"Sancak","year":"2022","journal-title":"Curr. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e01954","DOI":"10.1128\/mBio.01954-20","article-title":"Emergence of the Novel Aminoglycoside Acetyltransferase Variant aac(6\u2019)-Ib-D179Y and Acquisition of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Due to a Disrupting Mutation in the DNA Repair Enzyme MutS","volume":"11","author":"Sato","year":"2020","journal-title":"mBio"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/bioinformatics\/btu153","article-title":"Prokka: rapid prokaryotic genome annotation","volume":"30","author":"Seemann","year":"2014","journal-title":"Bioinformatics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/jac\/dkx066","article-title":"High ceftazidime hydrolysis activity and porin OmpK35 deficiency contribute to the decreased susceptibility to ceftazidime\/avibactam in KPC-producing Klebsiella pneumoniae","volume":"72","author":"Shen","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"6982","DOI":"10.1128\/AAC.03808-14","article-title":"Mechanisms of Tigecycline Resistance among Klebsiella pneumoniae Clinical Isolates","volume":"58","author":"Sheng","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e02097","DOI":"10.1128\/AAC.02097-16","article-title":"Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne bla(KPC-3) Mutations during Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010449","article-title":"Antibiotic heteroresistance in klebsiella pneumoniae","volume":"23","author":"Stojowska-Sw\u0119drzy\u0144ska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40262-018-0705-y","article-title":"Clinical pharmacokinetics and pharmacodynamics of ceftazidime-avibactam combination: A model-informed strategy for its clinical development","volume":"58","author":"Sy","year":"2019","journal-title":"Clin. Pharmacokinet."},{"key":"B50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1089\/fpd.2019.2701","article-title":"Characterization of salmonella enterica isolates from selected U.S. Swine feed mills by whole-genome sequencing","volume":"17","author":"Trinetta","year":"2020","journal-title":"Foodborne Pathog. Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/mmi.14197","article-title":"Streptococcal dTDP-L-rhamnose biosynthesis enzymes: functional characterization and lead compound identification","volume":"111","author":"van der Beek","year":"2019","journal-title":"Mol. Microbiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","article-title":"Resistance to ceftazidime-avibactam and underlying mechanisms","volume":"22","author":"Wang","year":"2020","journal-title":"J. Glob Antimicrob. Resist."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1571","article-title":"Molecular mechanisms underlying bacterial resistance to ceftazidime\/avibactam","volume":"14","author":"Xiong","year":"2022","journal-title":"WIREs Mech. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e02431","DOI":"10.1128\/AAC.02431-18","article-title":"Results from the China Antimicrobial Surveillance Network (CHINET) in 2017 of the In Vitro Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Clinical Isolates of Enterobacteriaceae and Pseudomonas aeruginosa","volume":"63","author":"Yin","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.682239","article-title":"Heteroresistance to amikacin in carbapenem-resistant klebsiella pneumoniae strains","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Microbiol."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.671153","article-title":"Characterization of tigecycline-heteroresistant klebsiella pneumoniae clinical isolates from a Chinese tertiary care teaching hospital","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Microbiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"124.e121","DOI":"10.1016\/j.cmi.2019.08.020","article-title":"Emergence of ceftazidime\/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5632","DOI":"10.1128\/AAC.02778-14","article-title":"Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis","volume":"58","author":"Zhang","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2018.00021","article-title":"Biofilm Formation in Klebsiella pneumoniae Bacteremia Strains Was Found to be Associated with CC23 and the Presence of wcaG","volume":"8","author":"Zheng","year":"2018","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41426-018-0141-y","article-title":"Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg. Microbes Infect."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1450530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:51:00Z","timestamp":1733467860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1450530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":60,"alternative-id":["10.3389\/fcimb.2024.1450530"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1450530","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,6]]},"article-number":"1450530"}}